Home Newsfeeds Piper Sandler Downgrades Occidental Petroleum to Neutral, Lowers Price Target to $76

Piper Sandler Downgrades Occidental Petroleum to Neutral, Lowers Price Target to $76

Piper Sandler analyst Ryan Todd downgrades Occidental Petroleum (NYSE:OXY) from Overweight to Neutral and lowers the price target from $78 to $76.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Piper Sandler analyst Ryan Todd downgrades Occidental Petroleum (NYSE:OXY) from Overweight to Neutral and lowers the price target from $78 to $76.

Investor Optimism Improves; S&P 500 Settles At Record High

By Avi Kapoor

June 11, 9:03 AM

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, but the index…

ASO

Elon Musk Effect Does It Again? Dogecoin, Shiba Inu, Floki Spike After X Owner Calls Platform A ‘Doge Friendly Place’

By Mehab Qureshi

August 24, 2:04 AM

In the midst of a sluggish week for meme coins, Dogecoin (CRYPTO: DOGE), Shiba Inu (CRYPTO: SHIB), and Floki (CRYPTO: FLOKI) on Thursday witnessed an uptic

$DOGE

Second Death – Pfizer Reports Young Boy’s Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial

By Vandana Singh

May 8, 1:09 PM

A young patient passed away from cardiac arrest after receiving Pfizer's experimental gene therapy for Duchenne muscular dystrophy. Pfizer investigates while trials continue, including Phase 3 study. Second death associated with the therapy.

PFE

Amazon, Snowflake And DataDog Shares Are Moving Following Microsoft’s Q2 Results: What’s Going On?

By Adam Eckert

January 24, 6:16 PM

Several cloud-related stocks are moving higher in Tuesday's after-hours session after Microsoft Corp (NASDAQ: MSFT) shares jumped on the company's quarterly results.

AMZN

Piper Sandler Downgrades Occidental Petroleum to Neutral, Lowers Price Target to $76

Related Posts

Investor Optimism Improves; S&P 500 Settles At Record High

Elon Musk Effect Does It Again? Dogecoin, Shiba Inu, Floki Spike After X Owner Calls Platform A ‘Doge Friendly Place’

Second Death – Pfizer Reports Young Boy’s Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial

Amazon, Snowflake And DataDog Shares Are Moving Following Microsoft’s Q2 Results: What’s Going On?